The Hanover Insurance Group Inc (THG)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at The Hanover Insurance Group Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 18 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 232.60 $ — 100% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
6 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 6.7% failed
- More than 10% revenue growth is expected for the coming year 4.4% failed
- Share count grows by less than 3% a year -0.4% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 23.9% failed
- Gross margin at 40% or higher and without meaningful erosion 43.5% passed
- Goodwill from acquisitions does not grow faster than revenue 1.1% passed
- Net debt below twice EBITDA 1,778 m net cash passed
- Operating cash flow covers the profits of the last three years 1,222 m passed
- Return on capital at 15% or higher, or up versus two years ago 14.8% passed
- Insiders hold at least 10% or are net buyers 0.9% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 0.7% below the current price.
- Consensus
- Sell
- Analyst Ratings
- 7
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 20.24 | 19.59 – 20.77 | 6,668 | 6.1% | 5 |
| 12/31/2027 | 19.21 | 18.35 – 20.24 | 6,954 | -5.1% | 8 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 4.59 | 53.90 | 1,578 | 3.20 | 10.60 | 214 | 211 |
| 2025: Q1 | 3.52 | 10.70 | 1,596 | 3.50 | 8.00 | 39 | 37 |
| 2025: Q2 | 4.32 | 286.80 | 1,651 | 7.50 | 9.50 | 207 | 205 |
| 2025: Q3 | 4.91 | 75.50 | 1,658 | 6.20 | 10.80 | 554 | 551 |
| 2025: Q4 | 5.47 | 19.20 | 1,672 | 5.90 | 11.90 | 378 | 377 |
| 2026: Q1 | 5.15 | 46.10 | 1,701 | 6.60 | 11.00 | 119 | 115 |
| 2026: Q2 | 5.38 | 24.50 | 1,726 | 4.60 | 11.10 | 212 | 209 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 3,966 | 66 | 155 | 3.59 | 743 | 2,858 | 14,220 |
| 2017 | 4,268 | 293 | 186 | 4.33 | 705 | 2,998 | 15,470 |
| 2018 | 4,466 | 283 | 391 | 9.09 | 551 | 2,955 | 12,400 |
| 2019 | 4,891 | 522 | 425 | 10.47 | 603 | 2,916 | 12,491 |
| 2020 | 4,819 | 445 | 359 | 9.41 | 708 | 3,202 | 13,444 |
| 2021 | 5,160 | 521 | 423 | 11.62 | 824 | 3,145 | 14,254 |
| 2022 | 5,433 | 144 | 116 | 3.21 | 722 | 2,334 | 13,995 |
| 2023 | 5,964 | 41 | 35 | 0.98 | 362 | 2,466 | 14,613 |
| 2024 | 6,217 | 538 | 426 | 11.70 | 806 | 2,842 | 15,275 |
| 2025 | 6,598 | 844 | 663 | 18.56 | 1,178 | 3,572 | 16,946 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
The Hanover Insurance Group, Inc. bietet über ihre Tochtergesellschaften verschiedene Sach- und Schadenversicherungsprodukte und -dienstleistungen für Privatpersonen und Unternehmen in den USA an.
| Employees | 4,900 |
|---|---|
| Headquarters | Worcester, MA |
| Address | 440 Lincoln Street, 01653 Worcester, United States |
| Phone | 508 855 1000 |
| Website | hanover.com |
| IPO Date | 10. Oct 1995 |
| ISIN | US4108671052 |
Management
| Name | Title | Birth Year |
|---|---|---|
| John Conner Roche | President, CEO & Director | 1964 |
| Jeffrey Mark Farber | Executive VP & CFO | 1965 |
| Richard William Lavey | Executive VP & COO | 1968 |
| Dennis Francis Kerrigan Jr. | Executive VP, Chief Legal Officer & Corporate Secretary | 1965 |
| Bryan James Salvatore | Executive VP & President of Specialty | 1965 |
| Lindsay France Greenfield | Senior VP & Chief investment Officer | – |
| Patricia Ann Norton-Gatto | Senior VP, Corporate Controller & Principal Accounting Officer | 1968 |
| Oksana Lukasheva | Senior Vice President of Corporate Finance | – |
| Toni E. Mitchell | President of Technology & Life Sciences Business | – |
| Willard Ty-Lunn Lee | Executive VP and Chief Information & Innovation Officer | 1970 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Farber Jeffrey M | Executive Vice President | Other | 49,330 | 232.34 | 11,461,332 |
| 29. Jul 2026 | Farber Jeffrey M | Executive Vice President | Other | 19,084 | 115.35 | 2,201,339 |
| 29. Jul 2026 | Farber Jeffrey M | Executive Vice President | Other | 26,832 | 118.54 | 3,180,665 |
| 29. Jul 2026 | Farber Jeffrey M | Executive Vice President | Other | 20,379 | 117.22 | 2,388,826 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.